Insider · CIK 0001591467

Butler John P.

CIK 0001591467 Name as filed on the most recent filing

Filed as Butler John P. (23)

33 transaction lines · from 23 filings · filed 2014-03-27 to 2026-03-05 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

33 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-03-04 P, Open-market purchase Akebia Therapeutics, Inc.AKBA 86,588, acquired Open Form 4 filing 0001591467-26-000003
2026-02-02 S, Open-market sale Akebia Therapeutics, Inc.AKBA 4 lines 474,414, disposed Open Form 4 filing 0001591467-26-000002
2025-03-03 S, Open-market sale Akebia Therapeutics, Inc.AKBA 84,928, disposed Open Form 4 filing 0001562180-25-001998
2025-02-03 S, Open-market sale Akebia Therapeutics, Inc.AKBA 2 lines 302,925, disposed Open Form 4 filing 0001562180-25-000917
2024-02-29 S, Open-market sale Akebia Therapeutics, Inc.AKBA 73,581, disposed Open Form 4 filing 0001562180-24-002021
2024-02-27 S, Open-market sale Akebia Therapeutics, Inc.AKBA 57,354, disposed Open Form 4 filing 0001562180-24-001992
2024-02-01 S, Open-market sale Akebia Therapeutics, Inc.AKBA 78,102, disposed Open Form 4 filing 0001562180-24-000971
2023-06-14 S, Open-market sale Zynerba Pharmaceuticals, Inc.ZYNE 40, disposed Open Form 4 filing 0001062993-23-013664
2023-03-01 S, Open-market sale Akebia Therapeutics, Inc.AKBA 3 lines 80,614, disposed Open Form 4 filing 0001562180-23-002201
2023-02-27 S, Open-market sale Akebia Therapeutics, Inc.AKBA 31,416, disposed Open Form 4 filing 0001562180-23-002041
2022-06-14 S, Open-market sale Zynerba Pharmaceuticals, Inc.ZYNE 54, disposed Open Form 4 filing 0001062993-22-015037
2022-03-01 S, Open-market sale Akebia Therapeutics, Inc.AKBA 3 lines 117,159, disposed Open Form 4 filing 0001562180-22-002166
2022-02-28 S, Open-market sale Akebia Therapeutics, Inc.AKBA 53,984, disposed Open Form 4 filing 0001562180-22-002166
2021-04-01 S, Open-market sale Akebia Therapeutics, Inc.AKBA 13,971, disposed Open Form 4 filing 0001562180-21-002540
2021-03-01 S, Open-market sale Akebia Therapeutics, Inc.AKBA 2 lines 169,771, disposed Open Form 4 filing 0001562180-21-001787
2019-11-20 P, Open-market purchase Akebia Therapeutics, Inc.AKBA 172,000, acquired Open Form 4 filing 0001562180-19-005623
2018-08-22 P, Open-market purchase Zynerba Pharmaceuticals, Inc.ZYNE 32,153, acquired Open Form 4 filing 0001192482-18-000409
2016-06-07 S, Open-market sale Relypsa IncRLYP 19,570, disposed Open Form 4 filing 0001140361-16-069149
2015-06-11 S, Open-market sale Relypsa IncRLYP 38,087, disposed Open Form 4 filing 0001140361-15-024343
2014-12-29 P, Open-market purchase Akebia Therapeutics, Inc.AKBA 11,567, acquired Open Form 4 filing 0001209191-14-078216
2014-12-22 P, Open-market purchase Akebia Therapeutics, Inc.AKBA 11,916, acquired Open Form 4 filing 0001209191-14-077383
2014-12-15 P, Open-market purchase Akebia Therapeutics, Inc.AKBA 11,336, acquired Open Form 4 filing 0001209191-14-076623
2014-11-12 P, Open-market purchase Akebia Therapeutics, Inc.AKBA 10,305, acquired Open Form 4 filing 0001209191-14-068410
2014-03-25 P, Open-market purchase Akebia Therapeutics, Inc.AKBA 235,450, acquired Open Form 4 filing 0001209191-14-023436

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 8
  • Open-market sale 25
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Butler John P., insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001591467

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.